Patent 8647667 was granted and assigned to Purdue Pharma on February, 2014 by the United States Patent and Trademark Office.
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.